Location History:
- Manhattan Beach, CA (US) (2014 - 2017)
- Fontana, CA (US) (2015 - 2021)
Company Filing History:
Years Active: 2014-2021
Title: Innovations by Madhuri Wadehra in Cancer Treatment
Introduction
Madhuri Wadehra is a prominent inventor based in Manhattan Beach, CA (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of novel antibodies. With a total of 6 patents, her work focuses on targeting specific proteins involved in cancer progression.
Latest Patents
Madhuri Wadehra's latest patents include groundbreaking inventions related to antibodies for the treatment of cancers. One notable patent describes novel anti-EMP2 antibodies that are useful for both the treatment and diagnosis of cancers that express or overexpress Epithelial Membrane Protein 2 (EMP2). This invention includes an isolated antibody that binds to EMP2, featuring a heavy chain variable region and a light chain variable region. The heavy chain variable region comprises three heavy chain complementary determining regions (HCDRs), while the light chain variable region includes three light chain variable regions (LCDRs). Specific sequences for these regions are detailed in the patent documentation. Another patent focuses on methods and compositions that inhibit the entry of pathogens into host cells expressing EMP2, thereby targeting cancers that express or overexpress EMP2 nucleic acids and polypeptides.
Career Highlights
Madhuri Wadehra has had a distinguished career, working with esteemed institutions such as the University of California and Memorial Sloan Kettering Cancer Center. Her research has been pivotal in advancing the understanding and treatment of cancer.
Collaborations
Madhuri has collaborated with notable colleagues, including Jonathan Braun and Lynn K Gordon, who have contributed to her research endeavors.
Conclusion
Madhuri Wadehra's innovative work in developing antibodies for cancer treatment showcases her dedication to advancing medical science. Her contributions are vital in the ongoing fight against cancer, and her patents reflect her commitment to improving patient outcomes.